CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Pentoxyverine

喷托维林 杂质对照品Pentoxyverine Impurities

EP30 个杂质条目30 impurity entries

本页汇总 喷托维林 的 30 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 30 impurity reference standards of Pentoxyverine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 喷托维林(Pentoxyverine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesFlow injection chemiluminescence method for the determination of pentoxyverine citrate based on NCS-dichlorofluorescein post-chemiluminescence reaction
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2009 · Zhang H et al.  ·  PMID 19155187  ·  DOI
  2. 分析方法Analytical MethodsA sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the simultaneous determination of pentoxyverine citrate and guaifenesin in human plasma---application to pharmacokinetic and bioequivalence studies
    Biomedical chromatography : BMC · 2010 · Wen J et al.  ·  PMID 19634120  ·  DOI
  3. 分析方法Analytical MethodsExtraction-free spectrophotometric assay of the antitussive drug pentoxyverine citrate using sulfonephthalein dyes
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2019 · Mohamed SH et al.  ·  PMID 31176152  ·  DOI
  4. 分析方法Analytical Methods[Bioequivalence evaluation of orally disintegrating tablet of pentoxyverine citrate]
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2010 · Lin MQ et al.  ·  PMID 20650784
  5. 分析方法Analytical Methods[Quantification of pentoxyverine citrate in human plasma by LC-ESI/MS method and its application]
    Yao xue xue bao = Acta pharmaceutica Sinica · 2009 · Yu KH et al.  ·  PMID 21351477

喷托维林 —— 原料药与杂质对照品Pentoxyverine — drug substance & impurities

共 30 个条目(含原料药本体)30 items incl. the drug substance
Pentoxyverine Impurity 1 (Pentoxyverine  EP Impurity A) structure
EPA
喷托维林杂质1(喷托维林EP杂质A)Pentoxyverine Impurity 1 (Pentoxyverine EP Impurity A)
Pentoxyverine Impurity 1 (Pentoxyverine EP Impurity A)
CAS No.77-55-4
Chemical FormulaC12H14O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 2 (Pentoxyverine  EP Impurity B) structure
EPB
喷托维林杂质2 (喷托维林EP杂质B)Pentoxyverine Impurity 2 (Pentoxyverine EP Impurity B)
Pentoxyverine Impurity 2 (Pentoxyverine EP Impurity B)
CAS No.77-22-5
Chemical FormulaC18H27NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Monomer structure
—
喷托维林 单体Pentoxyverine Monomer
Pentoxyverine Monomer
CAS No.77-23-6
Chemical FormulaC20H31NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 3 structure
3
喷托维林杂质3Pentoxyverine Impurity 3
Pentoxyverine Impurity 3
CAS No.105539-06-8
Chemical FormulaC12H15NO
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 4 structure
4
喷托维林杂质4Pentoxyverine Impurity 4
Pentoxyverine Impurity 4
CAS No.5296-89-9
Chemical FormulaC12H15NO
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 5 structure
5
喷托维林杂质5Pentoxyverine Impurity 5
Pentoxyverine Impurity 5
CAS No.77-57-6
Chemical FormulaC12H13N
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 7 structure
7
喷托维林杂质7Pentoxyverine Impurity 7
Pentoxyverine Impurity 7
CAS No.1378312-51-6
Chemical FormulaC16H23NO
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 8 structure
8
喷托维林杂质8Pentoxyverine Impurity 8
Pentoxyverine Impurity 8
CAS No.1421930-88-2
Chemical FormulaC14H18O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 10 structure
10
喷托维林杂质10Pentoxyverine Impurity 10
Pentoxyverine Impurity 10
CAS No.105539-03-5
Chemical FormulaC12H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 11 structure
11
喷托维林杂质11Pentoxyverine Impurity 11
Pentoxyverine Impurity 11
CAS No.29114-61-2
Chemical FormulaC14H17ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 12 structure
12
喷托维林杂质12Pentoxyverine Impurity 12
Pentoxyverine Impurity 12
CAS No.855910-45-1
Chemical FormulaC12H14ClN
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 16 structure
16
喷托维林杂质16Pentoxyverine Impurity 16
Pentoxyverine Impurity 16
CAS No.1421930-96-2
Chemical FormulaC18H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 18 structure
18
喷托维林杂质18Pentoxyverine Impurity 18
Pentoxyverine Impurity 18
CAS No.10487-96-4
Chemical FormulaC11H14O
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 19 structure
19
喷托维林杂质19Pentoxyverine Impurity 19
Pentoxyverine Impurity 19
CAS No.700-88-9
Chemical FormulaC11H14
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 20 structure
20
喷托维林杂质20Pentoxyverine Impurity 20
Pentoxyverine Impurity 20
CAS No.4535-95-9
Chemical FormulaC14H18O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 21 structure
21
喷托维林杂质21Pentoxyverine Impurity 21
Pentoxyverine Impurity 21
CAS No.79611-69-1
Chemical FormulaC8H18ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 25 structure
25
喷托维林杂质25Pentoxyverine Impurity 25
Pentoxyverine Impurity 25
CAS No.214262-97-2
Chemical FormulaC12H13FO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 26 structure
26
喷托维林杂质26Pentoxyverine Impurity 26
Pentoxyverine Impurity 26
CAS No.214262-96-1
Chemical FormulaC12H13FO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 27 structure
27
喷托维林杂质27Pentoxyverine Impurity 27
Pentoxyverine Impurity 27
CAS No.783297-14-3
Chemical FormulaC11H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 28 structure
28
喷托维林杂质28Pentoxyverine Impurity 28
Pentoxyverine Impurity 28
CAS No.143619-74-3
Chemical FormulaC11H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 29 structure
29
喷托维林杂质29Pentoxyverine Impurity 29
Pentoxyverine Impurity 29
CAS No.610791-44-1
Chemical FormulaC11H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 30 structure
30
喷托维林杂质30Pentoxyverine Impurity 30
Pentoxyverine Impurity 30
CAS No.1504254-89-0
Chemical FormulaC10H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 31 structure
31
喷托维林杂质31Pentoxyverine Impurity 31
Pentoxyverine Impurity 31
CAS No.1891346-46-5
Chemical FormulaC13H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 32 structure
32
喷托维林杂质32Pentoxyverine Impurity 32
Pentoxyverine Impurity 32
CAS No.1891346-43-2
Chemical FormulaC13H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 33 structure
33
喷托维林杂质33Pentoxyverine Impurity 33
Pentoxyverine Impurity 33
CAS No.1260802-79-6
Chemical FormulaC13H13F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 34 structure
34
喷托维林杂质34Pentoxyverine Impurity 34
Pentoxyverine Impurity 34
CAS No.878217-65-3
Chemical FormulaC13H13F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 35 structure
35
喷托维林杂质35Pentoxyverine Impurity 35
Pentoxyverine Impurity 35
CAS No.1260823-68-4
Chemical FormulaC13H13F3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 36 structure
36
喷托维林杂质36Pentoxyverine Impurity 36
Pentoxyverine Impurity 36
CAS No.102700-71-0
Chemical FormulaC22H29NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 37 structure
37
喷托维林杂质37Pentoxyverine Impurity 37
Pentoxyverine Impurity 37
CAS No.58819-37-7
Chemical FormulaC20H20N2
Purity>95%询价On request
10mg25mg50mg100mg
Pentoxyverine Impurity 38 structure
38
喷托维林杂质38Pentoxyverine Impurity 38
Pentoxyverine Impurity 38
CAS No.102075-13-8
Chemical FormulaC16H21ClO3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

喷托维林 —— 研究文献与合成路线Pentoxyverine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 喷托维林 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Pentoxyverine. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. Pentoxyverine voltoide and preparation method thereof
    LONGFU RAN, ZHI ZENG, BIAO CHEN, DAOJUN PU, et al. · 公开号 CN101536991CN101536991 · 2009
  2. Effervescence piece of Sulfogaiacol, pentoxyverine and promet hazine and preparation technique
    PENG DANMING · 公开号 CN1660113CN1660113 · 2005
  3. Sulfogaicol, pentoxyverine and promet-haz-ine drop pilles and preparing method thereof
    CHEN QIAN TENG · 公开号 CN1742733CN1742733 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

喷托维林 杂质谱研究要点Pentoxyverine — impurity profiling notes

下面这些是拿到 喷托维林 的 30 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 30 impurity entries for Pentoxyverine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances